Outlook Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.4M | 1.3M | 1.06 |
| 2025-06-30 | $2.0M | 1.3M | 1.60 |
| 2025-03-31 | $1.0M | 837k | 1.22 |
| 2024-12-31 | $1.6M | 853k | 1.89 |
| 2024-09-30 | $4.6M | 856k | 5.34 |
| 2024-06-30 | $4.0M | 548k | 7.38 |
| 2024-03-31 | $4.1M | 341k | 11.94 |